Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Montelukast + Loratadine vs. Montelukast for the Control of Mild to Moderate Persistent Asthma in Children: Randomized Controlled Clinical Trial

NCT03372473 is registered in ClinicalTrials.gov with Innovacion y Desarrollo de Estrategias en Salud as lead sponsor.

NCT NCT03372473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03372473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Montelukast + Loratadine vs. Montelukast for the Control of Mild to Moderate Persistent Asthma in Children: Randomized Controlled Clinical Trial
Lead sponsor
Innovacion y Desarrollo de Estrategias en Salud
Phase
Phase 3
Overall status
Completed
Start date
January 10, 2016
Completion date
June 30, 2017
Enrollment
80 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma in children